Clinical Trial Update: GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

The ClinicalTrials.gov update indicates termination of a Phase 1/2 study evaluating GLP-1 CellBeads for space-occupying intracerebral hemorrhage in stroke patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• GLP-1 CellBeads

Snippet

Sponsor: CellMed AG, a subsidiary of BTG plc. | Conditions: Intracerebral Hemorrhage (ICH) | Phase 1, Phase 2 | Status: TERMINATED